info@synchemia.com | sales@synchemia.com 
9766925136 
Baricitinib Nitroso Impurity 1
.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Baricitinib, also known as Olumiant, is used to treat rheumatoid arthritis. It's a type of drug known as a Janus kinase JAK inhibitor. It works by blocking the action of Janus kinase enzymes, which are involved in the inflammation that causes the symptoms of rheumatoid arthritis.Baricitinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Baricitinib Nitroso Impurity 1 CAS NO: NA chemically represented as 2-(1-(Ethylsulfonyl)-3-(4-(7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile. Synchemia is the leading manufacturing and exporter of Baricitinib Nitroso Impurity 1.We supply Baricitinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N014695 |
| CAS No | NA |
| Mol.F. | C21H41N7O9 |
| Mol.Wt. | 535.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014696 |
| CAS No | NA |
| Mol.F. | C11H16N2O4 |
| Mol.Wt. | 240.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N014697 |
| CAS No | NA |
| Mol.F. | C22H21F4N5O4 |
| Mol.Wt. | 495.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014698 |
| CAS No | NA |
| Mol.F. | C26H26N6O3 |
| Mol.Wt. | 470.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014699 |
| CAS No | NA |
| Mol.F. | C8H9N7O |
| Mol.Wt. | 219.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014700 |
| CAS No | NA |
| Mol.F. | C8H9N7O |
| Mol.Wt. | 219.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014701 |
| CAS No | NA |
| Mol.F. | C12H12FN3O2 |
| Mol.Wt. | 249.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014702 |
| CAS No | 67659-30-7 |
| Mol.F. | C6H10N2O3 |
| Mol.Wt. | 158.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014703 |
| CAS No | NA |
| Mol.F. | C25H21N5O5 |
| Mol.Wt. | 471.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014704 |
| CAS No | NA |
| Mol.F. | C27H31F2N9O |
| Mol.Wt. | 535.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014705 |
| CAS No | NA |
| Mol.F. | C6H9N7O2 |
| Mol.Wt. | 211.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014706 |
| CAS No | NA |
| Mol.F. | C46H61N5O12 |
| Mol.Wt. | 876.0 |
| INV STATUS | In Stock |
| CAT No | SRC-N014707 |
| CAS No | NA |
| Mol.F. | C28H24F3N7O2 |
| Mol.Wt. | 547.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014708 |
| CAS No | NA |
| Mol.F. | C6H7N3O |
| Mol.Wt. | 137.14 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014709 |
| CAS No | NA |
| Mol.F. | C21H20N4O6 |
| Mol.Wt. | 424.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014710 |
| CAS No | 16543-55-8 |
| Mol.F. | C9H11N3O |
| Mol.Wt. | 177.2 g/mol |
| INV STATUS | In Stock |
